Chembio Plans Dual Path Platform Tests For Syphilis, HIV
This article was originally published in The Gray Sheet
Executive Summary
Chembio Diagnostics will submit a 510(k) to FDA in 2010 for its Dual Path Platform Syphilis Screen & Confirm test, according to the company